2023
DOI: 10.57140/mj.53.1.5
|View full text |Cite
|
Sign up to set email alerts
|

High-volume post-obstructive choleresis (biliary hyperproduction) with acute kidney injury after choledochotomy, gallstones extraction, and T-tube drainage, successfully treated with octreotide

Abstract: Only several cases of postprocedural choleresis (biliary hyperproduction) were reported, and guidance on management is scarce, although an application of octreotide was anecdotally described. We herein present a rare post-obstructive choleresis complicated with acute kidney injury due to dehydration, successfully treated with an off-label application of octreotide. A 58-year-old female, following cholecystectomy and choledochotomy with numerous stones extraction, developed excessive bile loss via a T-tube comp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 6 publications
0
1
0
Order By: Relevance
“…In most patients (13 patients, 92%), a conservative approach was initiated, including pleural drainage, nil per mouth regime, total parenteral nutrition, and octreotide 0.1 mg bid subcutaneously. Although treatment with octreotide, a somatostatin analog is of unproven value, its use was described in the successful treatment of several off-label indications, including chylothorax [11,12]. Surgical treatment was indicated relatively early in patients with thoracic drain production >800 mL per day beyond the fifth day of treatment and in a patient with blunt thoracic trauma.…”
Section: Resultsmentioning
confidence: 99%
“…In most patients (13 patients, 92%), a conservative approach was initiated, including pleural drainage, nil per mouth regime, total parenteral nutrition, and octreotide 0.1 mg bid subcutaneously. Although treatment with octreotide, a somatostatin analog is of unproven value, its use was described in the successful treatment of several off-label indications, including chylothorax [11,12]. Surgical treatment was indicated relatively early in patients with thoracic drain production >800 mL per day beyond the fifth day of treatment and in a patient with blunt thoracic trauma.…”
Section: Resultsmentioning
confidence: 99%